Low serum Metrnl levels are associated with increased risk of sarcopenia in the older adults
- PMID: 39361190
- PMCID: PMC11632026
- DOI: 10.1007/s41999-024-01074-y
Low serum Metrnl levels are associated with increased risk of sarcopenia in the older adults
Abstract
Purpose: Sarcopenia is a geriatric syndrome characterized by progressive loss of muscle mass and function. Meteorin-like (Metrnl) is a secretory protein that has protective effects on skeletal muscle injury. However, the association of Metrnl level with sarcopenia remains unclear.
Methods: A total of 772 community-dwelling older adults (median age = 76 years), comprising 409 males and 363 females, from both urban and rural areas were enrolled. Serum Metrnl was measured by enzyme-linked immunosorbent assay. Appendicular skeletal muscle mass index (ASMI), grip strength, and gait speed were measured for the assessment of sarcopenia.
Results: We found that serum Metrnl levels were lower in patients with sarcopenia [median (IQR) = 180.1 (151.3-220.3) pg/mL] than older adults without sarcopenia [211.9 (163.2-270.0) pg/mL, P < 0.001]. Receiver-operating characteristic curve analysis showed that the optimal cut-off value of serum Metrnl level that predicted sarcopenia was 197.2 pg/mL with a sensitivity of 59.2% and a specificity of 63.8% (AUC = 0.63, 95% CI = 0.59-0.67, P < 0.001). Multivariate logistic regression analyses showed that lower serum Metrnl level (< 197.2 pg/mL) was significantly associated with increased risk of sarcopenia (adjusted OR = 2.358, 2.36, 95% CI = 1.528-3.685, P < 0.001). Moreover, serum Metrnl concentration was positively correlated with the components of sarcopenia including ASMI (r = 0.135, P < 0.001), grip strength (r = 0.102, P = 0.005), and gait speed (r = 0.106, P = 0.003).
Conclusions: Taken together, our findings demonstrate that low serum Metrnl level is correlated with increased risk of sarcopenia in the older adults.
Keywords: Metrnl; Older adults; Sarcopenia; Serum.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no conflicts of interest. Ethical approval: This study was approved by the Ethics Committee of Sir Run Run Hospital, Nanjing Medical University (Approval No. 2019-SR-S041). Informed consent: Written informed consent was obtained from each participant.
Figures
References
-
- Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Lijima K et al (2020) Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc 21:300–307. 10.1016/j.jamda.2019.12.012 - PubMed
-
- Ozawa M, Tamura K, Okano Y, Matsushita K, Ikeya Y, Masuda S et al (2009) Blood pressure variability as well as blood pressure level is important for left ventricular hypertrophy and brachial-ankle pulse wave velocity in hypertensives. Clin Exp Hypertens 31:669–679. 10.3109/10641960903407033 - PubMed
-
- Gao L, Jiang J, Yang M, Hao Q, Luo L, Dong B (2015) Prevalence of sarcopenia and associated factors in Chinese community-dwelling elderly: comparison between rural and urban areas. J Am Med Dir Assoc 16(1003):e1-6. 10.1016/j.jamda.2015.07.020 - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources